Monday 11th July 2022 |
Text too small? |
The Chair of Rua Bioscience Ltd (NZX: RUA ), Mr Trevor Burt, and the Rua Board are delighted to announce the appointment of Teresa Farac-Ciprian as an Independent Non-Executive Director, effective 1 August 2022.
This appointment reflects Rua’s decision to supplement its Board’s skill base as the company nears export market entry with its first products.
Teresa has an exceptional background in commercialisation, innovation, marketing and business development in the primary sector, specifically with dairy products, functional beverages and other foods on the global stage. She has significant international business experience, having held a variety of senior roles for Danone based in both North America and France focusing on their domestic and global markets. Teresa has also advised a number of internationally-focused businesses on their growth strategies and brings strong governance capability having served on the boards of Firstlight Foods Ltd, AgResearch, Prolife Foods, Food Standards Australia and New Zealand and Zespri. Teresa has a track record of helping develop highly capable leaders, strong brands, accumulation of IP and seeing organisations flourish through continuous improvement.
As required by Listing Rule 2.2.2 the Board has determined that Teresa is an independent director. Teresa will be eligible for re-election at the 2022 AGM.
Announcement of Director Appointment
No comments yet
AIA - June 2025 Monthly traffic update
CHI - Q2 2025 Operational Update
July 15th Morning Report
BPG - Blackpearl Acquires US AI Platform to Accelerate Growth
TGG - Response to media speculation
ARB - Annual Meeting Date and Director Nominations
CNU - Q4 FY25 Connections Update
MOVE FY25 Results and Investor Briefing 29 August 2025
RYM - First quarter trading update
July 11th Morning Report